SI-BONE, INC.
About SI-BONE, INC.
SI-BONE, Inc. (NASDAQ: SIBN) is a global leader in developing procedural solutions to address clinical challenges associated with compromised bone, with a focus on the sacropelvic anatomy. Founded in 2008 and headquartered in Santa Clara, CA, the company pioneered the iFuse Implant System, a proprietary minimally invasive surgical system for SI joint fusion. It has built a technology platform with market-leading applications centered on the spinopelvic anatomy and maintains a body of clinical evidence including randomized controlled trials. The company went public and continues to develop technologies targeting low-density bone challenges.
- 🔗 Si-Bone - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
- 🔗 SI-BONE - Products, Competitors, Financials, Employees, Headquarters Locations
- 🔗 SI-BONE Announces Pricing of Public Offering of Common Stock | SI-BONE, Inc.
- 🔗 SI-BONE, Inc. Reports Financial Results for the Second
- 🔗 SI-BONE (Nasdaq:SIBN) - Stock Analysis - Simply Wall St
Key highlights
- Pioneered iFuse Implant System for SI joint fusion with tens of thousands of patients treated.
- Completed multiple public offerings including $53.5M in 2020 and $83M follow-on.
- Maintains 12 institutional investors and strong clinical evidence base with RCTs.
- Headquartered in Santa Clara with focus on sacropelvic and spinopelvic anatomy solutions.
Ask StreetZero about SI-BONE, INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account